Cardlytics Historical Financial Ratios

CDLX Stock  USD 9.22  0.41  4.65%   
Cardlytics is presently reporting on over 104 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Dividend Yield of 0.0, PTB Ratio of 3.76 or Days Sales Outstanding of 170 will help investors to properly organize and evaluate Cardlytics financial condition quickly.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cardlytics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.
For more information on how to buy Cardlytics Stock please use our How to Invest in Cardlytics guide.

About Cardlytics Financial Ratios Analysis

CardlyticsFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Cardlytics investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Cardlytics financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Cardlytics history.

Cardlytics Financial Ratios Chart

Cardlytics financial ratios usually calculated using numerical values taken directly from Cardlytics financial statements such as income statements or balance sheets. They help investors to obtain meaningful information about Cardlytics. Most financial ratios help to conduct quantitative analysis to assess vital information about the company's valuation as well as profitability and liquidity indicators such as leverage, growth, profit margins, and different types of rates of return.
At this time, Cardlytics' Intangibles To Total Assets are fairly stable compared to the past year. Current Ratio is likely to rise to 1.56 in 2024, whereas Price To Sales Ratio is likely to drop 1.03 in 2024.
Add Fundamental
Price To Sales RatioDividend Yield
Ptb RatioDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesFree Cash Flow Per Share
RoicInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Payables TurnoverSales General And Administrative To Revenue
Average InventoryResearch And Ddevelopement To Revenue
Capex To RevenueCash Per Share
PocfratioInterest Coverage
Payout RatioCapex To Operating Cash Flow
Pfcf RatioDays Payables Outstanding
Net Current Asset ValueIncome Quality
RoeTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Graham NumberShareholders Equity Per Share
Debt To EquityCapex Per Share
Graham Net NetAverage Receivables
Revenue Per ShareInterest Debt Per Share
Debt To AssetsEnterprise Value Over E B I T D A
Short Term Coverage RatiosPrice Earnings Ratio
Operating CyclePrice Book Value Ratio
Price Earnings To Growth RatioDays Of Payables Outstanding
Dividend Payout RatioPrice To Operating Cash Flows Ratio
Price To Free Cash Flows RatioPretax Profit Margin
Ebt Per EbitOperating Profit Margin
Effective Tax RateCompany Equity Multiplier
Long Term Debt To CapitalizationTotal Debt To Capitalization
Return On Capital EmployedDebt Equity Ratio
Ebit Per RevenueQuick Ratio
Dividend Paid And Capex Coverage RatioNet Income Per E B T
Cash RatioCash Conversion Cycle
Operating Cash Flow Sales RatioDays Of Inventory Outstanding
Days Of Sales OutstandingFree Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage RatiosPrice To Book Ratio
Fixed Asset TurnoverCapital Expenditure Coverage Ratio
Price Cash Flow RatioEnterprise Value Multiple
Debt RatioCash Flow To Debt Ratio
Price Sales RatioReturn On Assets
Asset TurnoverNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On Equity

Price To Sales Ratio

Price to Sales Ratio is figured by comparing Cardlytics stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Cardlytics sales, a figure that is much harder to manipulate than other Cardlytics multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company’s stock price to its revenues, calculated by dividing the company’s market cap by its total sales or revenue over a 12-month period.

Ev To Sales

The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.

Inventory Turnover

A ratio showing how many times a company's inventory is sold and replaced over a period, indicating the efficiency of inventory management.
Most ratios from Cardlytics' fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Cardlytics current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cardlytics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.
For more information on how to buy Cardlytics Stock please use our How to Invest in Cardlytics guide.At this time, Cardlytics' Intangibles To Total Assets are fairly stable compared to the past year. Current Ratio is likely to rise to 1.56 in 2024, whereas Price To Sales Ratio is likely to drop 1.03 in 2024.
 2021 2022 2023 2024 (projected)
Payables Turnover35.4649.3840.0141.07
Days Of Inventory On Hand0.210.160.180.17

Cardlytics fundamentals Correlations

0.90.040.40.530.130.370.150.91.00.36-0.20.110.26-0.180.60.00.920.04-0.13-0.210.12-0.35-0.290.090.1
0.9-0.170.520.60.430.650.261.00.910.63-0.470.30.18-0.090.80.160.87-0.19-0.340.030.25-0.58-0.57-0.21-0.13
0.04-0.17-0.41-0.23-0.29-0.47-0.7-0.170.03-0.530.37-0.380.26-0.44-0.6-0.9-0.070.120.46-0.13-0.270.870.430.490.13
0.40.52-0.410.510.620.670.560.520.40.65-0.810.73-0.22-0.060.570.330.69-0.3-0.60.260.21-0.68-0.67-0.61-0.29
0.530.6-0.230.510.350.790.30.60.530.79-0.40.230.640.080.580.340.51-0.450.190.390.34-0.51-0.460.09-0.43
0.130.43-0.290.620.350.690.570.430.150.68-0.840.78-0.28-0.050.360.320.36-0.83-0.580.78-0.14-0.54-0.55-0.8-0.82
0.370.65-0.470.670.790.690.450.650.370.99-0.780.570.210.080.810.450.47-0.59-0.350.560.5-0.75-0.77-0.45-0.58
0.150.26-0.70.560.30.570.450.260.190.51-0.440.73-0.410.080.410.850.37-0.49-0.50.44-0.19-0.78-0.32-0.56-0.48
0.91.0-0.170.520.60.430.650.260.910.63-0.470.30.18-0.090.80.160.87-0.19-0.340.030.25-0.58-0.57-0.21-0.13
1.00.910.030.40.530.150.370.190.910.36-0.190.130.24-0.190.590.030.920.01-0.14-0.190.09-0.36-0.290.080.08
0.360.63-0.530.650.790.680.990.510.630.36-0.750.560.210.140.820.540.44-0.59-0.330.560.46-0.79-0.73-0.45-0.59
-0.2-0.470.37-0.81-0.4-0.84-0.78-0.44-0.47-0.19-0.75-0.670.2-0.18-0.56-0.28-0.430.510.67-0.48-0.150.630.60.810.5
0.110.3-0.380.730.230.780.570.730.30.130.56-0.67-0.55-0.40.380.390.44-0.64-0.70.630.05-0.57-0.68-0.74-0.64
0.260.180.26-0.220.64-0.280.21-0.410.180.240.210.2-0.550.250.08-0.16-0.010.00.78-0.020.250.160.150.690.01
-0.18-0.09-0.44-0.060.08-0.050.080.08-0.09-0.190.14-0.18-0.40.250.130.43-0.270.180.07-0.17-0.1-0.30.33-0.090.18
0.60.8-0.60.570.580.360.810.410.80.590.82-0.560.380.080.130.510.61-0.11-0.480.040.62-0.84-0.73-0.36-0.09
0.00.16-0.90.330.340.320.450.850.160.030.54-0.280.39-0.160.430.510.1-0.28-0.290.270.05-0.84-0.25-0.38-0.28
0.920.87-0.070.690.510.360.470.370.870.920.44-0.430.44-0.01-0.270.610.1-0.11-0.39-0.050.07-0.48-0.46-0.2-0.05
0.04-0.190.12-0.3-0.45-0.83-0.59-0.49-0.190.01-0.590.51-0.640.00.18-0.11-0.28-0.110.13-0.980.190.290.370.421.0
-0.13-0.340.46-0.60.19-0.58-0.35-0.5-0.34-0.14-0.330.67-0.70.780.07-0.48-0.29-0.390.13-0.1-0.090.570.540.90.12
-0.210.03-0.130.260.390.780.560.440.03-0.190.56-0.480.63-0.02-0.170.040.27-0.05-0.98-0.1-0.12-0.24-0.37-0.42-0.99
0.120.25-0.270.210.34-0.140.5-0.190.250.090.46-0.150.050.25-0.10.620.050.070.19-0.09-0.12-0.3-0.650.060.16
-0.35-0.580.87-0.68-0.51-0.54-0.75-0.78-0.58-0.36-0.790.63-0.570.16-0.3-0.84-0.84-0.480.290.57-0.24-0.30.630.580.27
-0.29-0.570.43-0.67-0.46-0.55-0.77-0.32-0.57-0.29-0.730.6-0.680.150.33-0.73-0.25-0.460.370.54-0.37-0.650.630.510.37
0.09-0.210.49-0.610.09-0.8-0.45-0.56-0.210.08-0.450.81-0.740.69-0.09-0.36-0.38-0.20.420.9-0.420.060.580.510.42
0.1-0.130.13-0.29-0.43-0.82-0.58-0.48-0.130.08-0.590.5-0.640.010.18-0.09-0.28-0.051.00.12-0.990.160.270.370.42
Click cells to compare fundamentals

Cardlytics Account Relationship Matchups

Cardlytics fundamentals Accounts

201920202021202220232024 (projected)
Price To Sales Ratio7.0920.797.970.651.091.03
Ptb Ratio10.4224.723.080.912.493.76
Days Sales Outstanding148.06169.04160.12146.81148.74169.72
Book Value Per Share6.035.7821.456.333.693.88
Free Cash Flow Yield2.93E-4(0.00456)(0.024)(0.35)(0.0374)(0.0393)
Invested Capital2.58E-41.20.291.111.932.02
Operating Cash Flow Per Share0.48(0.28)(1.2)(1.61)(0.00507)(0.005324)
Capex To Depreciation(2.43)(0.87)(0.35)(0.31)(0.42)(0.44)
Pb Ratio10.4224.723.080.912.493.76
Ev To Sales6.620.237.831.031.651.57
Free Cash Flow Per Share0.0184(0.65)(1.59)(2.02)(0.34)(0.36)
Roic(0.32)(0.12)(0.16)(0.1)(0.3)(0.31)
Inventory Turnover1.0K1.1K1.7K2.3K2.1K2.2K
Net Income Per Share(0.75)(2.15)(3.99)(13.92)(3.69)(3.88)
Days Of Inventory On Hand0.360.320.210.160.180.17
Payables Turnover106.5790.735.4649.3840.0141.07
Research And Ddevelopement To Revenue0.05560.09380.140.180.170.096
Capex To Revenue(0.0524)(0.0541)(0.047)(0.0452)(0.0401)(0.0421)
Cash Per Share4.410.787.253.652.523.14
Pocfratio130.28(511.35)(55.25)(3.58)(1.8K)(1.7K)
Capex To Operating Cash Flow(0.96)1.330.330.2566.9870.33
Pfcf Ratio3.4K(219.32)(41.66)(2.87)(26.72)(25.38)
Days Payables Outstanding3.434.0210.297.399.1211.21
Income Quality(0.67)0.140.30.120.0013730.001305
Roe(0.12)(0.37)(0.19)(2.2)(1.0)(1.05)
Ev To Operating Cash Flow121.17(497.51)(54.3)(5.69)(2.8K)(2.6K)
Pe Ratio(84.37)(66.45)(16.55)(0.42)(2.49)(2.62)
Return On Tangible Assets(0.0804)(0.14)(0.34)(1.75)(0.57)(0.6)
Ev To Free Cash Flow3.2K(213.38)(40.95)(4.55)(40.58)(38.55)
Earnings Yield(0.26)(0.0119)(0.015)(0.0604)(2.41)(0.42)
Intangibles To Total Assets0.0130.01870.0160.70.620.59
Net Debt To E B I T D A8.162.480.59(1.23)(5.1)(5.36)
Current Ratio2.54.741.11.01.311.56
Tangible Book Value Per Share5.865.53(5.92)(6.42)(5.54)(5.81)
Receivables Turnover2.492.472.162.282.451.9
Graham Number10.0616.7143.8944.5417.5220.63
Shareholders Equity Per Share6.035.7821.456.333.693.88

Cardlytics Investors Sentiment

The influence of Cardlytics' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Cardlytics. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Cardlytics' public news can be used to forecast risks associated with an investment in Cardlytics. The trend in average sentiment can be used to explain how an investor holding Cardlytics can time the market purely based on public headlines and social activities around Cardlytics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Cardlytics' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Cardlytics' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Cardlytics' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Cardlytics.

Cardlytics Implied Volatility

    
  106.29  
Cardlytics' implied volatility exposes the market's sentiment of Cardlytics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Cardlytics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Cardlytics stock will not fluctuate a lot when Cardlytics' options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Cardlytics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Cardlytics' short interest history, or implied volatility extrapolated from Cardlytics options trading.

Pair Trading with Cardlytics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cardlytics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cardlytics will appreciate offsetting losses from the drop in the long position's value.

Moving together with Cardlytics Stock

  0.69WLYB John Wiley SonsPairCorr
  0.62DIS Walt Disney Sell-off TrendPairCorr

Moving against Cardlytics Stock

  0.81ABTS Abits Group Symbol ChangePairCorr
  0.81TU Telus CorpPairCorr
  0.73EA Electronic Arts Financial Report 14th of May 2024 PairCorr
  0.71Z Zillow Group ClassPairCorr
  0.69ZG Zillow GroupPairCorr
The ability to find closely correlated positions to Cardlytics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cardlytics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cardlytics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cardlytics to buy it.
The correlation of Cardlytics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cardlytics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cardlytics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Cardlytics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Cardlytics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cardlytics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cardlytics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cardlytics Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cardlytics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.
For more information on how to buy Cardlytics Stock please use our How to Invest in Cardlytics guide.
You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Complementary Tools for Cardlytics Stock analysis

When running Cardlytics' price analysis, check to measure Cardlytics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cardlytics is operating at the current time. Most of Cardlytics' value examination focuses on studying past and present price action to predict the probability of Cardlytics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cardlytics' price. Additionally, you may evaluate how the addition of Cardlytics to your portfolios can decrease your overall portfolio volatility.
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Is Cardlytics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cardlytics. If investors know Cardlytics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cardlytics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.57)
Earnings Share
(3.69)
Revenue Per Share
8.033
Quarterly Revenue Growth
0.051
Return On Assets
(0.06)
The market value of Cardlytics is measured differently than its book value, which is the value of Cardlytics that is recorded on the company's balance sheet. Investors also form their own opinion of Cardlytics' value that differs from its market value or its book value, called intrinsic value, which is Cardlytics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cardlytics' market value can be influenced by many factors that don't directly affect Cardlytics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cardlytics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cardlytics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cardlytics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.